Results
|
1021.
|
|
|
1022.
|
|
|
1023.
|
Epithelial cell adhesion efficacy of a novel peptide identified by panning on a smooth titanium surface. [electronic resource] by
- Kihara, Hidemichi
- Kim, David M
- Nagai, Masazumi
- Nojiri, Toshiki
- Nagai, Shigemi
- Chen, Chia-Yu
- Lee, Cliff
- Hatakeyama, Wataru
- Kondo, Hisatomo
- Da Silva, John
Producer: 20190510
In:
International journal of oral science vol. 10
Availability: No items available.
|
|
1024.
|
|
|
1025.
|
|
|
1026.
|
|
|
1027.
|
Activation of the p38 pathway by a novel monoketone curcumin analog, EF24, suggests a potential combination strategy. [electronic resource] by
- Thomas, Shala L
- Zhao, Jing
- Li, Zijian
- Lou, Bin
- Du, Yuhong
- Purcell, Jamie
- Snyder, James P
- Khuri, Fadlo R
- Liotta, Dennis
- Fu, Haian
Producer: 20101006
In:
Biochemical pharmacology vol. 80
Availability: No items available.
|
|
1028.
|
|
|
1029.
|
|
|
1030.
|
|
|
1031.
|
|
|
1032.
|
|
|
1033.
|
|
|
1034.
|
HO-3867, a synthetic compound, inhibits the migration and invasion of ovarian carcinoma cells through downregulation of fatty acid synthase and focal adhesion kinase. [electronic resource] by
- Selvendiran, Karuppaiyah
- Ahmed, Shabnam
- Dayton, Alex
- Ravi, Yazhini
- Kuppusamy, M Lakshmi
- Bratasz, Anna
- Rivera, Brian K
- Kálai, Tamás
- Hideg, Kálmán
- Kuppusamy, Periannan
Producer: 20110303
In:
Molecular cancer research : MCR vol. 8
Availability: No items available.
|
|
1035.
|
|
|
1036.
|
The MDM2 Inhibitor AMG 232 Demonstrates Robust Antitumor Efficacy and Potentiates the Activity of p53-Inducing Cytotoxic Agents. [electronic resource] by
- Canon, Jude
- Osgood, Tao
- Olson, Steven H
- Saiki, Anne Y
- Robertson, Rebecca
- Yu, Dongyin
- Eksterowicz, John
- Ye, Qiuping
- Jin, Lixia
- Chen, Ada
- Zhou, Jing
- Cordover, David
- Kaufman, Stephen
- Kendall, Richard
- Oliner, Jonathan D
- Coxon, Angela
- Radinsky, Robert
Producer: 20160316
In:
Molecular cancer therapeutics vol. 14
Availability: No items available.
|
|
1037.
|
A First-in-Human Study of Novel Cereblon Modulator Avadomide (CC-122) in Advanced Malignancies. [electronic resource] by
- Rasco, Drew W
- Papadopoulos, Kyriakos P
- Pourdehnad, Michael
- Gandhi, Anita K
- Hagner, Patrick R
- Li, Yan
- Wei, Xin
- Chopra, Rajesh
- Hege, Kristen
- DiMartino, Jorge
- Shih, Kent
Producer: 20200226
In:
Clinical cancer research : an official journal of the American Association for Cancer Research vol. 25
Availability: No items available.
|
|
1038.
|
Iberdomide (CC-220) is a potent cereblon E3 ligase modulator with antitumor and immunostimulatory activities in lenalidomide- and pomalidomide-resistant multiple myeloma cells with dysregulated CRBN. [electronic resource] by
- Bjorklund, Chad C
- Kang, Jian
- Amatangelo, Michael
- Polonskaia, Ann
- Katz, Mark
- Chiu, Hsiling
- Couto, Suzana
- Wang, Maria
- Ren, Yan
- Ortiz, Maria
- Towfic, Fadi
- Flynt, J Erin
- Pierceall, William
- Thakurta, Anjan
Producer: 20200901
In:
Leukemia vol. 34
Availability: No items available.
|
|
1039.
|
|
|
1040.
|
|